Robin is an associate in the Antitrust Department, advising on merger control and foreign investment review for complex global transactions, and abuse of dominance investigations before international and national competition authorities. Utilising his background in organic chemistry, Robin has significant experience in advising life sciences, pharmaceutical and biotech companies. He has also advised public and private companies in a wide range of industries, including software, technology, energy and natural resource companies.
